RFL

Rafael Holdings Inc. (RFL) | Rumor.io

Rafael Holdings

RFL

Attention (50-day avg)0%

Attention rank (50-day avg)#2,453

Bullish sentiment (50-day avg)92%

Price to earnings ratio14.3

Market capitalization105M

Earnings per share-0.72

Dividend yield (TTM)2.6K%

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about RFL?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Jul 10

Rafael Holdings, Inc. ($RFL) has completed its Phase 3 trial for Trappsol Cyclo, a treatment for Niemann-Pick Disease Type C.
The company plans to submit a New Drug Application (NDA) in the latter half of 2026, aiming to transition into a commercial-stage biotechnology firm.
The stock has made a strong move up from $1.20 to nearly $3.80, with the next major milestones being the topline results readout and the NDA submission, both expected H2 2026.

Generated by AI

Sentiment

Of the messages about RFL that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% +57.14	62.5% -36.49	84.21% -4.67
Bearish	—	0% -57.14	37.5% +36.49	15.79% +4.67

Bullish· Jul 1

The company has a strong molecule with potential for significant growth, as indicated by the author's confidence in its market cap reaching $400M.
The stock has been making impressive gains, with one user up almost 200% on their investment and another regretting not buying more at a lower price.
The stock's volume is gaining momentum, with the author noting that it will be the first time that volumes have kept a reasonable pace with another stock, ZVRA.

Bearish· Nov 3

The RFL short sellers are in trouble, with the stock potentially experiencing a bigger decline in the next couple of days.
The stock's RSI is below 14, indicating a bearish trend, and short sellers may not be covered yet.
The stock's MACD Histogram has turned negative, indicating a downtrend, and the technical rating is bad, making it a potentially risky investment.

Generated by AI

Topics

Of the messages about RFL that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	51.82%
Announcements	—	—	0%	43.8%
Controversies	—	—	100%	3.65%
Analysts	—	—	0%	0%
Earnings	—	—	0%	0.73%
Macro	—	—	0%	0%

Announcements· Apr 4

Rafael Holdings, Inc. ($RFL) announced a $5 million share repurchase program, representing over 11% of its market capitalization at the time of the announcement.
The program was authorized by the company's board, with a specific focus on repurchasing shares to potentially increase shareholder value.
The market capitalization of Rafael Holdings, Inc. at the time of the announcement was approximately $45.32 million.

Technical Analysis· Oct 29

$RFL is showing potential for a bounce play, with a tight stop loss recommended, and the stock has gained vulture interest.
The stock has formed a bullish reversal pattern and may be due for an upside move, with a possible pop and squeeze if bulls take control.
Both the RSI and Stochastic indicators are in oversold territory on $RFL, suggesting a possible reversal and increase in the stock's price.

Generated by AI

Community

Of the messages about RFL, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	85.71%	91.3%	81.36%
Newcomers	0%	14.29%	8.7%	18.64%

Regulars· Oct 28

Rafael Holdings, Inc.'s stock price plummeted by 74.78% after its Phase 3 trial for CPI-613 failed to meet its primary endpoint.
The trial's failure has significant implications for Rafael Pharmaceuticals' pipeline, with the only compound in development now showing promise only in preclinical trials.
Regulars are focused on understanding the potential of the Barer Institute, a subsidiary of Rafael Holdings, and its potential value to the company's overall worth.

Newcomers· Jun 10

$RFL stock has ended the day up 27%, after this insider trade was reported last night, sparking interest in the stock.
The Robinhood/TikTok/WallStreetBets crowd appears to be driving Rafael Holdings' strong momentum, with the stock continuing to gain despite its relatively unknown status.
Some users are speculating about Rafael Holdings' potential for a parabolic rise, wondering if the stock's popularity is a result of the Robinhood crowd's discovery.

Generated by AI

Also Discussed

Investors talking about RFL also mention

#	Name	Attention
1	CYTH - Cyclo Therapeutics, Inc.	——
2	IDT Corporation Class B Common StockIDT	0%0
3	Viatris Inc.VTRS	0%0
4	Granite Point Mortgage Trust Inc.GPMT	0%0
5	ELEV - Elevation Oncology, Inc.	——
6	Interface, Inc.TILE	0%new
7	Virtus Investment Partners, Inc.VRTS	0%0
8	Genie Energy Ltd. Class B Common StockGNE	0%new
9	Office Properties Income TrustOPI	0%new
10	Gilat Satellite Networks Ltd.GILT	0%0

Rafael Holdings Inc.

Real Estate
Real Estate Services

Rafael Holdings Inc. operates as a holding company with a focus on healthcare and real estate. Its primary function is to invest in and support the development of biopharmaceutical ventures alongside managing a portfolio of commercial real estate properties. The company actively engages in the life sciences sector, where it holds interests in entities exploring innovative cancer and metabolic disease therapies. These ventures reflect its strategic aim to contribute to groundbreaking medical advancements. In addition to its biopharmaceutical interests, Rafael Holdings owns and oversees office buildings situated primarily in Newark, New Jersey. This dual focus on both healthcare innovations and real estate investments underscores the company's diversified business model. By balancing real estate stability with potential high-growth healthcare opportunities, Rafael Holdings positions itself uniquely within the financial market. It serves as a bridge between traditional real estate investment and cutting-edge biotech endeavors, leveraging its resources to create value across different sectors. As a public company, Rafael Holdings offers investors exposure to both tangible property assets and pioneering medical technology developments, reflecting its integral role in advancing healthcare solutions while maintaining a solid real estate foundation.

Website

Location

520 Broad Street

Newark, NJ, 07102

United States

Social

What share of all stock conversation is about RFL?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Jul 10

Rafael Holdings, Inc. ($RFL) has completed its Phase 3 trial for Trappsol Cyclo, a treatment for Niemann-Pick Disease Type C.
The company plans to submit a New Drug Application (NDA) in the latter half of 2026, aiming to transition into a commercial-stage biotechnology firm.
The stock has made a strong move up from $1.20 to nearly $3.80, with the next major milestones being the topline results readout and the NDA submission, both expected H2 2026.

Generated by AI

Sentiment

Of the messages about RFL that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% +57.14	62.5% -36.49	84.21% -4.67
Bearish	—	0% -57.14	37.5% +36.49	15.79% +4.67

Bullish· Jul 1

The company has a strong molecule with potential for significant growth, as indicated by the author's confidence in its market cap reaching $400M.
The stock has been making impressive gains, with one user up almost 200% on their investment and another regretting not buying more at a lower price.
The stock's volume is gaining momentum, with the author noting that it will be the first time that volumes have kept a reasonable pace with another stock, ZVRA.

Bearish· Nov 3

The RFL short sellers are in trouble, with the stock potentially experiencing a bigger decline in the next couple of days.
The stock's RSI is below 14, indicating a bearish trend, and short sellers may not be covered yet.
The stock's MACD Histogram has turned negative, indicating a downtrend, and the technical rating is bad, making it a potentially risky investment.

Generated by AI

Topics

Of the messages about RFL that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	51.82%
Announcements	—	—	0%	43.8%
Controversies	—	—	100%	3.65%
Analysts	—	—	0%	0%
Earnings	—	—	0%	0.73%
Macro	—	—	0%	0%

Announcements· Apr 4

Rafael Holdings, Inc. ($RFL) announced a $5 million share repurchase program, representing over 11% of its market capitalization at the time of the announcement.
The program was authorized by the company's board, with a specific focus on repurchasing shares to potentially increase shareholder value.
The market capitalization of Rafael Holdings, Inc. at the time of the announcement was approximately $45.32 million.

Technical Analysis· Oct 29

$RFL is showing potential for a bounce play, with a tight stop loss recommended, and the stock has gained vulture interest.
The stock has formed a bullish reversal pattern and may be due for an upside move, with a possible pop and squeeze if bulls take control.
Both the RSI and Stochastic indicators are in oversold territory on $RFL, suggesting a possible reversal and increase in the stock's price.

Generated by AI

Community

Of the messages about RFL, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	85.71%	91.3%	81.36%
Newcomers	0%	14.29%	8.7%	18.64%

Regulars· Oct 28

Rafael Holdings, Inc.'s stock price plummeted by 74.78% after its Phase 3 trial for CPI-613 failed to meet its primary endpoint.
The trial's failure has significant implications for Rafael Pharmaceuticals' pipeline, with the only compound in development now showing promise only in preclinical trials.
Regulars are focused on understanding the potential of the Barer Institute, a subsidiary of Rafael Holdings, and its potential value to the company's overall worth.

Newcomers· Jun 10

$RFL stock has ended the day up 27%, after this insider trade was reported last night, sparking interest in the stock.
The Robinhood/TikTok/WallStreetBets crowd appears to be driving Rafael Holdings' strong momentum, with the stock continuing to gain despite its relatively unknown status.
Some users are speculating about Rafael Holdings' potential for a parabolic rise, wondering if the stock's popularity is a result of the Robinhood crowd's discovery.

Generated by AI

Rafael Holdings

Social

Jul 10

Sentiment

Bullish· Jul 1

Bearish· Nov 3

Topics

Announcements· Apr 4

Technical Analysis· Oct 29

Community

Regulars· Oct 28

Newcomers· Jun 10

Also Discussed

Rafael Holdings Inc.

Company Information

Location

Also Discussed

Social

Jul 10

Sentiment

Bullish· Jul 1

Bearish· Nov 3

Topics

Announcements· Apr 4

Technical Analysis· Oct 29

Community

Regulars· Oct 28

Newcomers· Jun 10